TYMP and neoplasm: Western blot analysis indicated that intratumoral injection of TYMP shRNA complex in vivo significantly reduced the TYMP level in tumor tissue than those of control at 72 h post injection [see Additional file 3: Figure S3], confirming the effectiveness of intratumoral delivery of shRNA.